FTI
66
2
VIX
30
-2
NEE
62
2
SWKS
58
2
GOOGL
53
2
A
54
3
ORLY
62
4
PSX
42
2
ZBH
60
6
ADT
64
3
WAT
61
2
GOOG
75
2
QCOM
65
3
VFC
44
-3
K
41
-3
NFLX
72
-2
HSIC
53
3
HCA
55
-4
HP
30
5
LRCX
70
5
FTI
66
2
VIX
30
-2
NEE
62
2
SWKS
58
2
GOOGL
53
2
A
54
3
ORLY
62
4
PSX
42
2
ZBH
60
6
ADT
64
3
WAT
61
2
GOOG
75
2
QCOM
65
3
VFC
44
-3
K
41
-3
NFLX
72
-2
HSIC
53
3
HCA
55
-4
HP
30
5
LRCX
70
5
Financhill
Back

Apollo Asset Management, Inc. Vs. Akero Therapeutics Industry Stock Comparison

Buy
53

APO
Apollo Asset Management, Inc.

Last Price:
$138.11
Seasonality Move:
3%
Buy
66

AKRO
Akero Therapeutics

Last Price:
$52.94
Seasonality Move:
26.74%
Buy
53
Apollo Asset Management, Inc. (APO) is a Buy

Is Apollo Asset Management, Inc. a Buy, Sell or Hold?

  • The current Apollo Asset Management, Inc. [APO] share price is $135.62. The Score for APO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • APO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $54.52. The Score for AKRO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APO Stock Price Chart

What is Apollo Asset Management, Inc.'s stock price today?

  • The Apollo Asset Management, Inc. share price today is $135.62
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APO is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $54.52
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

APO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.54 Sell
Relative Strength Index (14 RSI): 54.17 Buy
Chaikin Money Flow: 1953600 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (129.36 - 140.32) Buy
Bollinger Bands (100): (127.17 - 157.97) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.33 Buy
Relative Strength Index (14 RSI): 70.35 Buy
Chaikin Money Flow: 708985 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.73 - 51.79) Buy
Bollinger Bands (100): (35.84 - 51.64) Buy

APO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 131.93 Buy
20-day SMA: 135.16 Buy
50-day SMA: 131.61 Buy
200-day SMA: 144.22 Sell
8-day EMA: 132.98 Buy
20-day EMA: 133.41 Buy
50-day EMA: 135.23 Buy
200-day EMA: 137.93 Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.8 Buy
20-day SMA: 47.39 Buy
50-day SMA: 42.93 Buy
200-day SMA: 36.38 Buy
8-day EMA: 52.61 Buy
20-day EMA: 49 Buy
50-day EMA: 45.35 Buy
200-day EMA: 38.09 Buy

Apollo Asset Management, Inc. Earnings Growth & APO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.32 per share, an increase this year of $0.67 per share, and an increase next year of $1.61 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

Apollo Asset Management, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):